Michael Williams

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction

Daníel F. Guðbjartsson, Unnur Steina Björnsdóttir, Eva Halapi et al. · Nature Genetics · 2009 · 759 citations

Asthma, Immunogenetics, Allergy +11

A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma

Patrick Flood-Page, Cheri A. Swenson, Isidore Faiferman et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 737 citations

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

36th International Symposium on Intensive Care and Emergency Medicine

R. M. Bateman, Michael D. Sharpe, Justin E. Jagger et al. · Critical Care · 2016 · 485 citations · Full text